In September 2022, the Company announced and implemented a cost restructuring program impacting approximately 6% of the Company’s global headcount. This strategic reduction was intended to manage the Company’s operating expenses in response to market conditions and ongoing business prioritization efforts.

The restructuring expenses recognized in the consolidated statements of loss for the year ended December 31, 2022, primarily consisting of one-time incremental employee termination benefits and other costs related to Company’s business prioritization, were as follows:

	Year ended December 31, 2022
Cost of revenues	$	99
Research and development		1,815
Sales and marketing		1,176
General and administrative		293
Total restructuring expenses recognized in the consolidated statements of loss	$	3,383

As of December 31, 2022, $88 related to restructuring expenses were included in “Accrued expenses and other current liabilities” in the consolidated balance sheet, and were subsequently paid in 2023.